Brief: Revive Therapeutics enters into a exclusive license agreement with South Carolina Research Foundation
19/09/2017 12:03
Sept 19 (Reuters) - Revive Therapeutics Ltd RVV.V
* Revive Therapeutics-co, South Carolina Research Foundation
enter into exclusive license agreement for cannabinoids-based
therapeutics in treatment of liver diseases
* Revive Therapeutics Ltd - Revive will pay SCRF a nominal
one time fee for entering into license
Source text for Eikon: ID:nCCNxYTwxa
Further company coverage: RVV.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure